Interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors are the most important immunotherapies for COVID-19 (Angriman et al., 2021; Elahi et al., 2022; Levy et al., 2022; RECOVERY Collaborative Group, 2022). This evidence concerns the gene IL6 and COVID-19.